The whole country has its ear turned toward Washington, eagerly listening for how we’ll be affected by the myriad proposed disruptions to healthcare policy. Notwithstanding the legitimate... Read more
We’d like to extend our congratulations to Dr. Michael Rosenberg, our CEO and resident author, on the release of his new book: The Agile Approach to Adaptive Research: Optimizing... Read more
After a year of legislation and congressional speculation insulating medical device makers from lawsuits and economic penalties, it looks as though the FDA will replace its favor with the same... Read more
At the Fourth Annual Site Solutions Summit in October , 150 site stakeholders and two dozen sponsors and CROs achieved consensus on six site best practices. Organizers of the event said if... Read more
The Triangle Business Journal reported yesterday that scientists from the BC Cancer Agency have decoded the DNA of metastatic lobular breast cancer, which accounts for about 10 percent of all... Read more
Lilly’s renovation plans are big news in pharma this week—starting January 1, 2010, the company will adopt a majorly restructured operating model in hopes of reducing cost, boosting... Read more
The New York Times ’ recent article on Boeing’s delays getting its new 787 Dreamliner off the ground should hit close to home for many of us in the drug development industry.... Read more
In a recent report , Britain’s NICE (National Institute for Health and Clinical Excellence) has just touched on the tipping point for how pharma will handle the approaching... Read more
We are very pleased to announce the new and improved Healthdec.com. Our goal is to provide you with latest information and content related to increasing the efficiency of clinical development.... Read more
